US Stock MarketDetailed Quotes
CRBU Caribou Biosciences
- 1.600
- +0.010+0.63%
Close Jul 2 16:00 ET
- 1.600
- 0.0000.00%
Post 19:57 ET
144.51MMarket Cap-1159P/E (TTM)
1.640High1.535Low1.67MVolume1.600Open1.590Pre Close2.64MTurnover2.42%Turnover RatioLossP/E (Static)90.32MShares8.59052wk High0.42P/B110.45MFloat Cap1.53552wk Low--Dividend TTM69.03MShs Float32.645Historical High--Div YieldTTM6.60%Amplitude1.535Historical Low1.581Avg Price1Lot Size
About Caribou Biosciences Company
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Company Profile
SymbolCRBU
Company NameCaribou Biosciences
Listing DateJul 23, 2021
Issue Price16.00
Founded2011
CEODr. Rachel Haurwitz, PhD
MarketNASDAQ
Employees158
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2929 7th Street,Suite 105
CityBerkeley
ProvinceCalifornia
CountryUnited States of America
Zip Code94710
Phone1-510-982-6030
Websitehttp://www.cariboubio.com
Company Executives
- Name
- Position
- Salary
- Dr. Rachel Haurwitz, PhD
- President, Chief Executive Officer and Director
- 3.12M
- Dr. Steven B. Kanner, PhD
- Chief Scientific Officer
- 1.22M
- Jason V. O’Byrne
- Chief Financial Officer and Principal Accounting Officer
- --
- Ruhi Ahmad Khan
- Chief Business Officer
- --
- Tim Kelly
- Chief Technology Officer
- --
- Barbara G. McClung, J.D.
- Chief Legal Officer and Corporate Secretary
- 1.22M
- Andrew L. Guggenhime
- Chairman of the Board
- 202.74K
- Ran Zheng
- Independent Director
- 157.20K
- David L. Johnson, C.P.A.
- Independent Director
- 143.85K
- Dr. Natalie Sacks
- Independent Director
- 136.99K
- Dr. Nancy C. Whiting, Pharm.D.
- Independent Director
- 140.62K
- Dr. Scott Braunstein, M.D.
- Independent Director
- 155.86K
- Dr. Dara Richardson-Heron
- Independent Director
- 141.93K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
